Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases

European Journal of Surgical Oncology

Volumn 27, Issue 1, 2001, Pages 80-87

  Petrowsky, H ^a,b   Sturm, I ^c   Graubitz, O ^a   Kooby, D A ^b   Staib Sebler, E ^a   Gog, C ^a   Kohne C H ^c   Hillebrand, T ^d   Daniel, P T ^c,e   Fong, Y ^b   Lorenz, M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d VI Systems GmbH   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Colorectal cancer; K ras; Ki 67; Liver metastases

Indexed keywords

DNA; KI 67 ANTIGEN;

ADULT; AGED; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CODON; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SAMPLE; SCORING SYSTEM; SIGNAL TRANSDUCTION; SURVIVAL TIME;

EID: 0035098522     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.1029     Document Type: Article

References (58)

1. Failure patterns following curative resection of colonic carcinoma
2. Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
3. Colorectal metastases to the liver: Present status of management
4. Current perspectives on repeat hepatic resection for colorectal carcinoma: A review
5. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of pattern of recurrence
6. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients
7. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases
8. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer
9. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
10. Rate of growth of intraabdominal metastases from colorectal cancer
11. Growth rate of hepatic metastases in colorectal carcinoma
12. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
13. Genetic alterations during colorectal development
14. A genetic model for colorectal tumorigenesis
15. The pathway to signal achievement
16. Increasing complexity of Ras signaling
17. The biochemistry of ras p21
18. Functions of oncogenes and tumor suppressor genes
19. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification
20. K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic diseases
21. A microplate assay for K-ras genotyping
22. Nonparametric estimation from incomplete observations
23. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship
24. Evaluation of survival data and two new rank order statistics arising in its consideration
25. Regression models and life tables
26. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical application
27. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIBI
28. Monoclonal antibody Ki67: Its use in histopathology
29. Evidence for quiescent S-and G2-phase cells in human colorectal carcinomas: A flow cytometric study with the Ki-67 antibody
30. Production of a mouse monocolonal antibody reactive with a human nuclear antigen associated with cell proliferation
31. Cell production rates in human tissue and tumours and their significance. Part I: An introduction to the techniques of measurement and their limitations
32. Cell proliferation related markers in colorectal liver metastases: Correlation with patient prognosis
33. Proliferation of invasive breast carcinomas and colorectal carcinomas: An immunohistochemical in situ investigation with the monoclonal antibody Ki-67
34. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma
35. An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinoma
36. Heterogenity in proliferation markers in colorectal cancer
37. Determination of proliferative activity in colorectal carcinoma using monocolonal antibody Ki67
38. Increased expression of sialyl Lewis A and sialyl Lewis X in liver metastases of human colorectal carcinoma
39. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling
40. FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
41. Clinical relevance of transforming growth factor α, epidermal growth factor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors
42. p53 is a persistent and predictive marker in advanced ovarian carcinomas: Multivariate analysis including comparison with Ki67 immunoreactivity
43. Ki67 antigen immunostaining (MIB I monoclonal antibody) in serous ovarian tumors: Index of proliferative activity with prognostic significance
44. Ki67 immunoreactivity in breast carcinoma: Relationships to prognostic variables and short term survival
45. Apoptosis in breast carcinoma
46. Prognostic significance of Ki67 labelling in resected non small cell lung cancer
47. C-erb-2 oncoprotein expression in operable non-small cell lung cancer
48. Prevalence of ras gene mutations in human colorectal cancer
49. K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer
50. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
51. C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas
52. Detection of DDC and Ki-ras gene alternations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence
53. Clinical and pathological associations with allelic loss in colorectal carcinoma
54. Survival and acquired genetic alternations in colorectal cancer
55. Prognostic significance of K-ras mutations in colorectal carcinoma
56. K-ras mutations in patients with early colorectal cancer
57. P53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer
58. K-ras status does not predict successful hepatic resection of colorectal cancer metastasis